Nathan B Fountain Selected Research

fosphenytoin (Cerebyx)

1/2022	A critical review of fosphenytoin sodium injection for the treatment of status epilepticus in adults and children.
1/2021	Early Exposure of Fosphenytoin, Levetiracetam, and Valproic Acid After High-Dose Intravenous Administration in Young Children With Benzodiazepine-Refractory Status Epilepticus.
11/2020	Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
1/2020	The association of patient weight and dose of fosphenytoin, levetiracetam, and valproic acid with treatment success in status epilepticus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nathan B Fountain Research Topics

Disease

19	Seizures (Absence Seizure) 01/2021 - 05/2002
13	Epilepsy (Aura) 01/2019 - 07/2003
8	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022 - 02/2014
2	Temporal Lobe Epilepsy 12/2018 - 01/2018
2	Sudden Unexpected Death in Epilepsy 01/2018 - 10/2017
2	Hippocampal Sclerosis 12/2017 - 01/2017
1	Dizziness (Lightheadedness) 11/2015
1	Diplopia (Double Vision) 11/2015
1	Nausea 11/2015
1	Partial Epilepsies (Epilepsy, Partial) 03/2015
1	Autism Spectrum Disorder 09/2013
1	Drug Resistant Epilepsy 04/2013
1	Memory Disorders (Memory Loss) 09/2012
1	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 09/2012
1	Obesity 08/2012
1	Migraine Disorders (Migraine) 08/2012
1	Chronic Pain 08/2012
1	Sleep Deprivation 11/2007
1	Hyperventilation 10/2004
1	Epileptic Syndromes 07/2003

Drug/Important Bio-Agent (IBA)

9	Anticonvulsants (Antiepileptic Drugs)IBA 10/2017 - 05/2002
7	Pharmaceutical PreparationsIBA 01/2021 - 07/2003
6	Valproic Acid (Depakote)FDA LinkGeneric 01/2021 - 07/2003
5	BenzodiazepinesIBA 01/2021 - 01/2019
5	Levetiracetam (Keppra)FDA LinkGeneric 01/2021 - 05/2002
5	Lacosamide FDA Link 11/2015 - 03/2008
4	fosphenytoin (Cerebyx)FDA LinkGeneric 01/2022 - 01/2020
2	Lamotrigine (Lamictal)FDA LinkGeneric 06/2010 - 07/2003
2	Topiramate (Topamax)FDA LinkGeneric 06/2010 - 07/2003
2	Carbamazepine (Tegretol)FDA LinkGeneric 06/2010 - 04/2007
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 12/2017
1	Complement System Proteins (Complement)IBA 06/2015
1	salicylhydroxamic acid (SHAM)IBA 03/2014
1	Anesthetics (Anesthetic Agents)IBA 02/2014
1	Proteins (Proteins, Gene)FDA Link 09/2013
1	AntibodiesIBA 09/2012
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 06/2010
1	Ethosuximide (Zarontin)FDA LinkGeneric 07/2003

Therapy/Procedure

9	Therapeutics 11/2020 - 05/2002
3	Anterior Temporal Lobectomy 01/2019 - 01/2018
2	Vagus Nerve Stimulation 01/2017 - 01/2017
1	Intravenous Administration 01/2021
1	Electrodes (Electrode) 06/2015
1	Deep Brain Stimulation 03/2015
1	Transcranial Magnetic Stimulation 11/2007